Liberator Medical Holdings, Inc. is a direct-to-consumer provider of medical supplies, primarily to Medicare-eligible seniors. The Company's segment includes Mail Order Supplies. The Company markets its products to individuals with chronic illnesses who require continuous access to medical devices and supplies. It is a quasi-medical distributor providing home healthcare services. The Company distributes products that are classified as durable medical equipment (DME). It offers urological catheters, ostomy supplies, mastectomy fashions and diabetic supplies. It offers female intermittent catheters, indwelling female catheters and external catheters. It offers ostomy supplies, including colostomy, ileostomy and urostomy supplies. Its diabetes testing supplies include glucose meters, glucose test strips, control solution and lancets, offering diabetes testing supplies from the diabetes supply manufacturers. The Company offers mastectomy bras and mastectomy breast forms.
Industry, Sector and Symbol:
- Sector: Non-Cyclical Consumer Goods & Services
- Industry: Retail - Drugs without Grocery
- Sub-Industry: N/A
- Symbol: NYSEMKT:LBMH
- CUSIP: N/A
- Web: www.liberatormedical.com
- 50 Day Moving Avg: $3.34
- 200 Day Moving Avg: $2.72
- 52 Week Range: $1.96 - $3.90
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 19.71
- P/E Growth: 0.00
- Net Margins: 7.14%
- Return on Equity: 18.13%
- Return on Assets: 10.19%
- Average Volume: 347,035 shs.
Frequently Asked Questions for Liberator Medical Holdings (NYSEMKT:LBMH)
What is Liberator Medical Holdings' stock symbol?
Liberator Medical Holdings trades on the New York Stock Exchange (NYSE)MKT under the ticker symbol "LBMH."
How were Liberator Medical Holdings' earnings last quarter?
Liberator Medical Holdings Inc (NYSEMKT:LBMH) announced its quarterly earnings data on Monday, February, 9th. The company reported $0.05 earnings per share for the quarter, meeting the Thomson Reuters' consensus estimate of $0.05. Liberator Medical Holdings had a return on equity of 18.13% and a net margin of 7.14%. View Liberator Medical Holdings' Earnings History.
Who are some of Liberator Medical Holdings' key competitors?
Some companies that are related to Liberator Medical Holdings include Unilever plc (ULVR), British American Tobacco PLC (BTI), British American Tobacco plc (BATS), Diageo plc (DGE), Reckitt Benckiser Group Plc (RB), Constellation Brands (STZ), Imperial Brands PLC (IMB), Associated British Foods plc (ABF), Tesco PLC (TSCO), Kerry Group Public Ltd Co (KYGA), Coca Cola HBC AG (CCH), US Foods Holding Corp (USFD), WM Morrison Supermarkets PLC (MRW), J Sainsbury plc (SBRY), Booker Group Plc (BOK), Nord Anglia Education (NORD), Tate & Lyle PLC (TATE) and Fevertree Drinks PLC (FEVR).
How do I buy Liberator Medical Holdings stock?
Shares of Liberator Medical Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Liberator Medical Holdings' stock price today?
MarketBeat Community Rating for Liberator Medical Holdings (NYSEMKT LBMH)MarketBeat's community ratings are surveys of what our community members think about Liberator Medical Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Liberator Medical Holdings stock can currently be purchased for approximately $3.35.
Consensus Ratings for Liberator Medical Holdings (NYSEMKT:LBMH) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Liberator Medical Holdings (NYSEMKT:LBMH)
(Data available from 9/19/2015 forward)
|10/29/2015||Singular Research||Initiated Coverage||Buy||$3.60|
Earnings History for Liberator Medical Holdings (NYSEMKT:LBMH)Earnings History by Quarter for Liberator Medical Holdings (NYSEMKT LBMH)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Earnings Estimates for Liberator Medical Holdings (NYSEMKT:LBMH)
Current Year EPS Consensus Estimate: $0.17 EPS
Next Year EPS Consensus Estimate: $0.17 EPS
Dividend History by Quarter for Liberator Medical Holdings (NYSEMKT LBMH)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Liberator Medical Holdings (NYSEMKT:LBMH)Insider Trades by Quarter for Liberator Medical Holdings (NYSEMKT:LBMH)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|1/21/2016||Bard C. R. Inc /Nj/||Major Shareholder||Buy||1,000||$0.01||$10.00|| |
|2/17/2015||Millennium Partners, L.P.||Major Shareholder||Sell||416,200||$3.66||$1,523,292.00|| |
|2/12/2015||Millennium Partners, L.P.||Major Shareholder||Sell||200,000||$3.54||$708,000.00|| |
|2/6/2015||Millennium Partners, L.P.||Major Shareholder||Sell||175,000||$3.43||$600,250.00|| |
|1/30/2015||Millennium Partners, L.P.||Major Shareholder||Sell||75,000||$3.27||$245,250.00|| |
|1/28/2015||Millennium Partners, L.P.||Major Shareholder||Sell||100,000||$3.17||$317,000.00|| |
|1/15/2015||Millennium Partners, L.P.||Major Shareholder||Sell||50,000||$3.15||$157,500.00|| |
|6/27/2014||Millennium Partners, L.P.||Major Shareholder||Sell||100,000||$4.00||$400,000.00|| |
|6/24/2014||Millennium Partners, L.P.||Major Shareholder||Sell||175,000||$4.05||$708,750.00|| |
|1/21/2014||Millennium Partners, L.P.||Major Shareholder||Sell||85,000||$5.99||$509,150.00|| |
|1/17/2014||Millennium Partners, L.P.||Major Shareholder||Sell||210,000||$5.72||$1,201,200.00|| |
|1/15/2014||Millennium Partners, L.P.||Major Shareholder||Sell||649,079||$5.19||$3,368,720.01|| |
|1/9/2014||Millennium Partners, L.P.||Major Shareholder||Sell||279,123||$4.67||$1,303,504.41|| |
|12/24/2013||Millennium Partners, L.P.||Major Shareholder||Sell||100,000||$4.36||$436,000.00|| |
|11/29/2013||Millennium Partners, L.P.||Major Shareholder||Sell||75,000||$3.65||$273,750.00|| |
|11/25/2013||Millennium Partners, L.P.||Major Shareholder||Sell||180,000||$3.20||$576,000.00|| |
|10/14/2013||Millennium Partners, L.P.||Major Shareholder||Sell||240,000||$2.20||$528,000.00|| |
|9/17/2013||Millennium Partners, L.P.||Major Shareholder||Sell||215,000||$2.25||$483,750.00|| |
|8/21/2013||Robert Joseph Davis||CFO||Buy||1,000||$1.49||$1,490.00|| |
|7/15/2013||Millennium Partners, L.P.||Major Shareholder||Sell||300,000||$1.83||$549,000.00|| |
|4/22/2013||Jeannette Maria Corbett||Director||Buy||20,000||$1.05||$21,000.00|| |
Headline Trends for Liberator Medical Holdings (NYSEMKT:LBMH)
Latest Headlines for Liberator Medical Holdings (NYSEMKT:LBMH)
No headlines for this company have been tracked by MarketBeat.com